Paul Musey to Opioid-Related Disorders
This is a "connection" page, showing publications Paul Musey has written about Opioid-Related Disorders.
Connection Strength
0.302
-
Punches BE, Stolz U, Freiermuth CE, Ancona RM, McLean SA, House SL, Beaudoin FL, An X, Stevens JS, Zeng D, Neylan TC, Clifford GD, Jovanovic T, Linnstaedt SD, Germine LT, Bollen KA, Rauch SL, Haran JP, Storrow AB, Lewandowski C, Musey PI, Hendry PL, Sheikh S, Jones CW, Kurz MC, Gentile NT, McGrath ME, Hudak LA, Pascual JL, Seamon MJ, Harris E, Chang AM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sanchez LD, Bruce SE, Pietrzak RH, Joormann J, Barch DM, Pizzagalli DA, Smoller JW, Luna B, Harte SE, Elliott JM, Kessler RC, Ressler KJ, Koenen KC, Lyons MS. Predicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study. PLoS One. 2022; 17(9):e0273378.
Score: 0.178
-
Kahler ZP, Musey PI, Schaffer JT, Johnson AN, Strachan CC, Shufflebarger CM. Effect Of A "No Superuser Opioid Prescription" Policy On ED Visits And Statewide Opioid Prescription. West J Emerg Med. 2017 Aug; 18(5):894-902.
Score: 0.124